Eyenovia to Present at Upcoming BTIG Ophthalmology Day

Rhea-AI Summary

Eyenovia, Inc. (Nasdaq: EYEN) announced its participation in the BTIG Ophthalmology Day scheduled for November 29, 2022. The company will showcase its innovative Optejet® delivery system, aimed at treating mydriasis, presbyopia, and pediatric progressive myopia. Management will present from 1:30 to 1:55 PM ET and engage in one-on-one meetings with investors. Eyenovia is focused on late-stage development of microdose array print therapeutics. More details are available on Eyenovia’s corporate website.

NEW YORK, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (Nasdaq: EYEN), a pre-commercial ophthalmic technology company developing the Optejet® delivery system for use both in combination with its own drug-device therapeutic programs for mydriasis, presbyopia and pediatric progressive myopia as well as out-licensing for additional indications, today announced management will present at the BTIG Ophthalmology Day taking place virtually on November 29, 2022. Presentation details are below:

BTIG Ophthalmology Day

Date:	Tuesday, November 29, 2022
Time:	1:30 – 1:55 PM ET

The Eyenovia management team will be participating in one-on-one meetings at the event. Investors interested in meeting with Eyenovia at either conference should contact their BTIG representative.

About Eyenovia, Inc.

Eyenovia, Inc. (Nasdaq: EYEN) is a pre-commercial ophthalmic technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia and myopia progression. For more information, visit Eyenovia.com.

The Eyenovia Corporate Information slide deck may be found at ir.eyenovia.com/events-and-presentations.

Eyenovia Contact:
Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
jgandolfo@eyenovia.com

Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
eric@lifesciadvisors.com
(646) 751-4363

Eyenovia Media Contact:
Norbert Lowe
Vice President, Commercial Operations
Eyenovia
nlowe@eyenovia.com

FAQ

What is the date of the BTIG Ophthalmology Day for Eyenovia?

The BTIG Ophthalmology Day for Eyenovia is on November 29, 2022.

What time will Eyenovia present at the BTIG Ophthalmology Day?

Eyenovia will present from 1:30 to 1:55 PM ET.

What is the focus of Eyenovia's therapeutic programs?

Eyenovia's therapeutic programs focus on mydriasis, presbyopia, and pediatric progressive myopia.

Where can I find more information about Eyenovia?

More information about Eyenovia can be found on their website at Eyenovia.com.

Who can investors contact for meetings with Eyenovia during the conference?

Investors interested in meetings with Eyenovia should contact their BTIG representative.